Head-to-head · WeighScore
Harmon.Health vs LifeMD
By GLP-1 ScorecardUpdated
Score comparison
Harmon.Health has the higher recorded score — 74/100 to 57.8/100.
Harmon.Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harmon.Health sells compounded semaglutide and tirzepatide at one price for every dose, plus dissolving tablets and the brand Wegovy pill, but its site links to no published terms.
Before you choose
Before comparing the headline prices, the Harmon.Health review and the LifeMD review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Harmon.Health vs No BS RX and HealthRX vs LifeMD compare each of them with another graded program, and the list of alternatives to Harmon.Health ranks the programs closest to Harmon.Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Lttl review covers one graded close to these two, at 63.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Harmon.Health | LifeMD |
|---|---|---|
| WeighScore | 74/100 | 57.8/100 |
| Grade | C | C |
| Site position | #72 | #423 |
| Semaglutide | $149/mo (month-to-month; $389 billed quarterly or $1,249 yearly, same price at every dose, compounded) | Brand Wegovy from $199 (pen) or $149 (pill); plus a program fee of $39 the first month, then $149/mo (the page also cites $75/mo) |
| Tirzepatide | $199/mo (month-to-month; $499 billed quarterly or $1,599 yearly, same price at every dose, compounded) | Brand Zepbound vial from $299; plus a program fee of $39 the first month, then $149/mo |
| Coverage | All states except Mississippi | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #72 · C
Strengths
- Same price at every dose, with quarterly and yearly plans
- Offers injections, dissolving tablets and the brand Wegovy pill
- Serves every state except Mississippi
What to consider
- The Terms of Service, telehealth consent and privacy notice links in the footer lead nowhere
- Neither the prescribing physicians nor the pharmacies are named
- Introductory prices run until December 1, 2026, and some prices depend on a separate club membership
Strengths
- Telehealth convenience
- Physician-supervised program
What to consider
- Brand-name GLP-1 only — no lower-cost compounded option
- Monthly program & provider fee ($149/mo, $75 first month) is separate from medication cost
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.